BRE-06: Study to Increase Tolerance to Aromatase Inhibitors for Patients With Early-Stage Hormone Receptor Positive Breast Cancer Who Developed Hypoactive Sexual Desire Disorder

Clinical trial NCT07596212 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07596212
Sponsor: University of Illinois at Chicago
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Early-stage Breast Cancer Hypoactive Sexual Desire Disorder Hormone Receptor Positive Breast Carcinoma Breast Cancer

Start date: 2026-07-01
Primary completion: 2028-07-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.